COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France.

COVID-19 exposure Healthcare workers Humoral response Personal protective equipment SARS-CoV-2

Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 23 06 2021
revised: 23 08 2021
accepted: 09 11 2021
pubmed: 15 11 2021
medline: 2 2 2022
entrez: 14 11 2021
Statut: ppublish

Résumé

Strasbourg University Hospital faced an important COVID-19 first wave from early March 2020. We performed a longitudinal prospective cohort study to describe clinical and virological data, exposure history to COVID-19, and adherence to strict hygiene standards during the first pandemic wave in 1497 workers undergoing a SARS-CoV-2 serological test at our hospital, with a follow up of serology result three months later. A total of 1497 patients were enrolled from April 6 to May 7, 2020. Antibody response to SARS-CoV-2 was measured, and COVID-19 exposure routes were analyzed according to SARS-CoV-2 serological status. A total of 515 patients (34.4%) were seropositive, mainly medical students (13.2%) and assistant nurses (12.0%). A history of COVID-19 exposure in a professional and/or private setting was mentioned by 83.1% of seropositive subjects (P<0.05; odds ratio [OR]: 2.5; 95% confidence interval [CI]: 1.8-3.4). COVID-19 exposure factors associated with seropositive status were non-professional exposure (OR: 1.9, 95% CI: 1.3-2.7), especially outside the immediate family circle (OR: 2.2, 95% CI: 1.2-3.9) and contact with a COVID-19 patient (OR: 1.6; 95% CI: 1.1-2.2). Among professionally exposed workers, systematic adherence to strict hygiene standards was well observed, except for the use of a surgical mask (P<0.05, OR: 1.9, 95% CI: 1.3-2.8). Of those who reported occasionally or never wearing a surgical mask, nurses (25.7%), assistant nurses (16.2%), and medical students (11.7%) were predominant. Infection of staff members during the first pandemic wave in our hospital occurred after both professional and private COVID-19 exposure, underlining the importance of continuous training in strict hygiene standards.

Identifiants

pubmed: 34775140
pii: S2666-9919(21)00539-X
doi: 10.1016/j.idnow.2021.11.002
pmc: PMC8582228
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-30

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Références

Clin Infect Dis. 2021 Aug 2;73(3):e754-e764
pubmed: 33560412
Emerg Infect Dis. 2021 Jan;27(1):
pubmed: 33261718
Med Leg J. 2020 Jul;88(2):65-66
pubmed: 32441196
Diagn Microbiol Infect Dis. 2020 Dec;98(4):115181
pubmed: 32957073
Eur Respir Rev. 2020 Apr 3;29(155):
pubmed: 32248146
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
Otolaryngol Head Neck Surg. 2020 Oct;163(4):671-672
pubmed: 32482123
Pediatr Allergy Immunol. 2020 Oct;31(7):841-847
pubmed: 32413201
Nat Commun. 2020 Jul 8;11(1):3500
pubmed: 32641730
J Microbiol Immunol Infect. 2021 Feb;54(1):54-60
pubmed: 32359943
Clin Infect Dis. 2020 Nov 19;71(16):2218-2221
pubmed: 32179890
Nat Commun. 2020 Oct 8;11(1):5064
pubmed: 33033249
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
J Infect Dis. 2021 Sep 17;224(6):983-988
pubmed: 33693749
N Engl J Med. 2020 May 21;382(21):e63
pubmed: 32237672

Auteurs

Aurélie Velay (A)

Virology Laboratory and INSERM UMR_S 1109, Strasbourg University Hospital, 3, rue Koeberlé, 67000 Strasbourg, France; Strasbourg University, INSERM, IRM UMR-S 1109, 67000 Strasbourg, France. Electronic address: aurelie.velay@chru-strasbourg.fr.

Floriane Gallais (F)

Virology Laboratory and INSERM UMR_S 1109, Strasbourg University Hospital, 3, rue Koeberlé, 67000 Strasbourg, France; Strasbourg University, INSERM, IRM UMR-S 1109, 67000 Strasbourg, France.

Marie-Josée Wendling (MJ)

Virology Laboratory and INSERM UMR_S 1109, Strasbourg University Hospital, 3, rue Koeberlé, 67000 Strasbourg, France.

Sophie Bayer (S)

CHU de Strasbourg, Laboratoire de Biochimie Clinique et Biologie Moléculaire, 67091 Strasbourg, France.

Nathalie Reix (N)

CHU de Strasbourg, Laboratoire de Biochimie Clinique et Biologie Moléculaire, 67091 Strasbourg, France.

Anne Schneider (A)

CHU de Strasbourg, Département de Génétique Moléculaire du cancer, 67091 Strasbourg, France.

Ludovic Glady (L)

CHU de Strasbourg, Laboratoire de Biochimie Clinique et Biologie Moléculaire, 67091 Strasbourg, France.

Nicolas Collongues (N)

Centre d'investigation Clinique INSERM 1434, CHU Strasbourg, Strasbourg, France.

Jean-Marc Lessinger (JM)

CHU de Strasbourg, Laboratoire de Biochimie Clinique et Biologie Moléculaire, 67091 Strasbourg, France.

Yves Hansmann (Y)

CHU de Strasbourg, Service des maladies infectieuses et tropicales, 67091 Strasbourg, France.

Laurence Kling-Pillitteri (L)

CHU de Strasbourg, Service de santé au travail du personnel hospitalier, 67091 Strasbourg, France.

Jérome De Sèze (J)

Centre d'investigation Clinique INSERM 1434, CHU Strasbourg, Strasbourg, France.

Maria Gonzalez (M)

CHU de Strasbourg, Service de santé au travail du personnel hospitalier, 67091 Strasbourg, France; CHU de Strasbourg, Service de Pathologies Professionnelles, Strasbourg, France.

Catherine Schmidt-Mutter (C)

Centre d'investigation Clinique INSERM 1434, CHU Strasbourg, Strasbourg, France.

Nicolas Meyer (N)

CHU de Strasbourg, Service de santé Publique, GMRC, 67091 Strasbourg, France.

Samira Fafi-Kremer (S)

Virology Laboratory and INSERM UMR_S 1109, Strasbourg University Hospital, 3, rue Koeberlé, 67000 Strasbourg, France; Strasbourg University, INSERM, IRM UMR-S 1109, 67000 Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH